Suppr超能文献

新型乙酰氧肟酸对大鼠胃黏膜5-脂氧合酶抑制作用未能预防乙醇诱导的损伤。

Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.

作者信息

Boughton-Smith N K, Whittle B J

机构信息

Department of Pharmacology, Wellcome Research Laboratories, Beckenham, Kent.

出版信息

Br J Pharmacol. 1988 Sep;95(1):155-62. doi: 10.1111/j.1476-5381.1988.tb16559.x.

Abstract
  1. The role of leukotriene B4 (LTB4) and LTC4 as mediators of gastric mucosal damage following ethanol challenge in vivo has been investigated using two selective 5-lipoxygenase inhibitors, BW A4C and BW A137C. 2. Oral administration of ethanol to rats in vivo, induced macroscopic damage to the gastric mucosa and markedly increased the formation of the 5-lipoxygenase products, LTB4 and LTC4, from the mucosa ex vivo. 3. Pretreatment with the acetohydroxamic acids BW A4C and BW A137C (5-50 mg kg-1 p.o.) dose-dependently reduced ethanol-stimulated LTB4 and LTC4 formation by the gastric mucosa, with an ID50 of approximately 5 mg kg-1 p.o. 4. A single oral dose of BW A4C (20 mg kg-1) induced near-maximal inhibition of mucosal LTB4 formation within 30 min, which was well maintained for 5 h, whereas BW A137C (20 mg kg-1 p.o.) induced maximal inhibition between 30 and 60 min after administration, which then diminished over the subsequent 5 h. 5. The mucosal formation of the cyclo-oxygenase product, 6-keto-prostaglandin F1 alpha, which was unaltered following ethanol challenge, was not inhibited by the acetohydroxamic acids. Likewise, the small increase in mucosal thromboxane B2 formation following challenge was not inhibited by BW A4C. 6. Neither BW A4C nor BW A137C, at doses that almost completely inhibited the mucosal synthesis of LTB4 or LTC4, reduced the macroscopic gastric mucosal damage induced by ethanol. 7. Pretreatment with the lipoxygenase inhibitor BW 755C (5-50 mg kg-1 p.o.) did reduce mucosal damage, but there was a dissociation between the degree of protection and the inhibition of leukotriene biosynthesis. 8. Oral administration of high doses of either BW A4C or BW A137C (300mgkg-1) did not induce macroscopic gastric damage over a 3 h period. 9. These findings suggest that the leukotrienes, LTB4 and LTC4 are not the primary mediators of ethanol-induced acute mucosal damage, but do not exclude their role in more chronic gastric damage and inflammation.
摘要
  1. 利用两种选择性5-脂氧合酶抑制剂BW A4C和BW A137C,研究了白三烯B4(LTB4)和LTC4在体内乙醇刺激后作为胃黏膜损伤介质的作用。2. 给大鼠口服乙醇可在体内引起胃黏膜的肉眼可见损伤,并显著增加离体胃黏膜中5-脂氧合酶产物LTB4和LTC4的生成。3. 用乙酰氧肟酸BW A4C和BW A137C(5 - 50毫克/千克,口服)预处理可剂量依赖性地减少乙醇刺激引起的胃黏膜LTB4和LTC4生成,口服半数抑制剂量(ID50)约为5毫克/千克。4. 单次口服剂量的BW A4C(20毫克/千克)在30分钟内可引起黏膜LTB4生成近乎最大程度的抑制,并在5小时内保持良好效果;而BW A137C(20毫克/千克,口服)在给药后30至60分钟内引起最大抑制,随后在接下来的5小时内逐渐减弱。5. 环氧化酶产物6-酮-前列腺素F1α的黏膜生成在乙醇刺激后未改变,乙酰氧肟酸对此也无抑制作用。同样,刺激后黏膜血栓素B2生成的小幅增加也未被BW A4C抑制。6. 无论是BW A4C还是BW A137C,在几乎完全抑制LTB4或LTC4黏膜合成的剂量下,均未减轻乙醇引起的肉眼可见的胃黏膜损伤。7. 用脂氧合酶抑制剂BW 755C(5 - 50毫克/千克,口服)预处理确实可减轻黏膜损伤,但保护程度与白三烯生物合成抑制之间存在分离。8. 口服高剂量的BW A4C或BW A137C(300毫克/千克)在3小时内未引起肉眼可见的胃损伤。9. 这些发现表明,白三烯LTB4和LTC4不是乙醇诱导的急性黏膜损伤的主要介质,但不排除它们在更慢性的胃损伤和炎症中的作用。

相似文献

7
8
Involvement of leukotrienes in acute gastric damage.
Methods Find Exp Clin Pharmacol. 1989;11 Suppl 1:53-9.

引用本文的文献

本文引用的文献

6
A radioimmunoassay for leukotriene B4.白三烯B4的放射免疫测定法。
Prostaglandins. 1982 Aug;24(2):225-35. doi: 10.1016/0090-6980(82)90148-4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验